| Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells R Moriggl, DJ Topham, S Teglund, V Sexl, C McKay, D Wang, ... Immunity 10 (2), 249-259, 1999 | 650 | 1999 |
| Nonredundant roles for Stat5a/b in directly regulating Foxp3 Z Yao, Y Kanno, M Kerenyi, G Stephens, L Durant, WT Watford, ... Blood 109 (10), 4368-4375, 2007 | 632 | 2007 |
| Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth FM Corvinus, C Orth, R Moriggl, SA Tsareva, S Wagner, EB Pfitzner, ... Neoplasia 7 (6), 545-555, 2005 | 406 | 2005 |
| Autocrine PDGFR signaling promotes mammary cancer metastasis M Jechlinger, A Sommer, R Moriggl, P Seither, N Kraut, P Capodiecci, ... The Journal of clinical investigation 116 (6), 1561-1570, 2006 | 388 | 2006 |
| Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype R Moriggl, V Gouilleux-Gruart, R Jähne, S Berchtold, C Gartmann, X Liu, ... Molecular and cellular biology 16 (10), 5691-5700, 1996 | 316 | 1996 |
| Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense … KJ Aichberger, M Mayerhofer, MT Krauth, H Skvara, S Florian, K Sonneck, ... Blood 105 (8), 3303-3311, 2005 | 264 | 2005 |
| Stat5 tetramer formation is associated with leukemogenesis R Moriggl, V Sexl, L Kenner, C Duntsch, K Stangl, S Gingras, A Hoffmeyer, ... Cancer cell 7 (1), 87-99, 2005 | 255 | 2005 |
| Stat5 is indispensable for the maintenance of bcr/abl‐positive leukaemia A Hoelbl, C Schuster, B Kovacic, B Zhu, M Wickre, MA Hoelzl, S Fajmann, ... EMBO molecular medicine 2 (3), 98-110, 2010 | 253 | 2010 |
| Bone homeostasis in growth hormone receptor–null mice is restored by IGF-I but independent of Stat5 NA Sims, P Clément-Lacroix, F Da Ponte, Y Bouali, N Binart, R Moriggl, ... The Journal of clinical investigation 106 (9), 1095-1103, 2000 | 252 | 2000 |
| Stat5a/b contribute to interleukin 7–induced B-cell precursor expansion, but abl- andbcr/abl-induced transformation are independent of Stat5 V Sexl, R Piekorz, R Moriggl, J Rohrer, MP Brown, KD Bunting, ... Blood, The Journal of the American Society of Hematology 96 (6), 2277-2283, 2000 | 251 | 2000 |
| Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy JP Tuckermann, A Kleiman, R Moriggl, R Spanbroek, A Neumann, A Illing, ... The Journal of clinical investigation 117 (5), 1381-1390, 2007 | 250 | 2007 |
| Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation A Hoelbl, B Kovacic, MA Kerenyi, O Simma, W Warsch, Y Cui, H Beug, ... Blood 107 (12), 4898-4906, 2006 | 250 | 2006 |
| Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation M Kieslinger, I Woldman, R Moriggl, J Hofmann, JC Marine, JN Ihle, ... Genes & development 14 (2), 232-244, 2000 | 233 | 2000 |
| A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis K Kollmann, G Heller, C Schneckenleithner, W Warsch, R Scheicher, ... Cancer cell 24 (2), 167-181, 2013 | 230 | 2013 |
| Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells R Moriggl, V Sexl, R Piekorz, D Topham, JN Ihle Immunity 11 (2), 225-230, 1999 | 230 | 1999 |
| Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway H Schnidar, M Eberl, S Klingler, D Mangelberger, M Kasper, ... Cancer research 69 (4), 1284-1292, 2009 | 224 | 2009 |
| Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription E Stoecklin, M Wissler, R Moriggl, B Groner Molecular and Cellular Biology 17 (11), 6708-6716, 1997 | 210 | 1997 |
| High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia W Warsch, K Kollmann, E Eckelhart, S Fajmann, S Cerny-Reiterer, ... Blood, The Journal of the American Society of Hematology 117 (12), 3409-3420, 2011 | 203 | 2011 |
| Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5 KD Bunting, HL Bradley, TS Hawley, R Moriggl, BP Sorrentino, JN Ihle Blood, The Journal of the American Society of Hematology 99 (2), 479-487, 2002 | 181 | 2002 |
| Apoptosis protection by the Epo target Bcl-XL allows factor-independent differentiation of primary erythroblasts H Dolznig, B Habermann, K Stangl, EM Deiner, R Moriggl, H Beug, ... Current Biology 12 (13), 1076-1085, 2002 | 164 | 2002 |
Lukas KennerProf. für Experimentelle PathologieVerified email at vetmeduni.ac.at
